JILLIAN FETZNER: Open Payments
NPI 1588060321 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,718 in 71 payments from 24 companies in 2025. Trend: 2023 $1,502 · 2024 $1,609 · 2025 $1,718
Food & beverage: $1,675Education: $43
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $245 |
| Sequel Med Tech, LLC | 7 | $235 |
| Mannkind Corporation | 8 | $165 |
| Neurocrine BioSciences, Inc. | 5 | $135 |
| Madrigal Pharmaceuticals | 3 | $105 |
| Xeris Pharmaceuticals, Inc. | 5 | $97 |
| Abbott Laboratories | 4 | $78 |
| Lilly USA, LLC | 4 | $70 |
| SANOFI-AVENTIS U.S. LLC | 2 | $64 |
| Averitas Pharma Inc. | 2 | $57 |
Products named: TWIIST, AFREZZA, CRENESSITY, REZDIFFRA, Ozempic, FREESTYLE LIBRE 3, TZIELD, KEVEYIS.
Industry payments across OH — which companies pay providers there.
